Literature DB >> 966077

Improved and effective assays of the glutamic oxaloacetic transaminase by the coenzyme-apoenzyme system (CAS) principle.

H Kishi, K Folkers.   

Abstract

Standardized and reliable methods have been devised to assay preparations of the glutamic oxaloacetic transaminase from human erythrocytes by the CAS principle, i.e., the unsaturation and saturation of the coenzyme (pyridoxal 5'-phosphate) of a Coenzyme-Apoenzyme System. This dual enzymic assay is effective to detect and measure human deficiencies of vitamin B6. A preferred procedure has been developed, particularly for individuals and for limited groups, but is also applicable to large groups. A simplified procedure, which emphasizes the statistical significance of difference between large groups was also developed. Lyophilized erythrocyte hemolysates appear stable for up to 7 days for simplified transportation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 966077     DOI: 10.3177/jnsv.22.225

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  4 in total

1.  Biochemical evidence for a deficiency of vitamin B6 in the carpal tunnel syndrome based on a crossover clinical study.

Authors:  K Folkers; J Ellis; T Watanabe; S Saji; M Kaji
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  Apparent inhibition of erythrocyte glutamic oxaloacetic transaminase in subjects on large dosages of B-6.

Authors:  A Sohler; C C Pfeiffer
Journal:  Experientia       Date:  1981-11-15

3.  Response of vitamin B-6 deficiency and the carpal tunnel syndrome to pyridoxine.

Authors:  J M Ellis; K Folkers; M Levy; S Shizukuishi; J Lewandowski; S Nishii; H A Schubert; R Ulrich
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

4.  Enzymology of the response of the carpal tunnel syndrome to riboflavin and to combined riboflavin and pyridoxine.

Authors:  K Folkers; A Wolaniuk; S Vadhanavikit
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.